A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of zinc-dependent extracellular enzymes that play a crucial role in a myriad of biological processes. These enzymes are active participants in the cleavage, restructuring, and maintenance of the extracellular matrix (ECM), which is a vital component of tissues and organs. Members of the ADAMTS family are involved in the proteolytic processing of various substrates within the ECM. Its signaling mechanisms are embedded within a web of regulatory pathways that include cytokine networks, growth factors, and other enzymes. These pathways modulate ADAMTS expression levels and enzymatic activity, implicating it in ECM remodeling, cell migration, and the modulation of other cellular behaviors. Factors like epigenetic regulation, substrate availability, and endogenous further add layers of complexity to the regulation of ADAMTS activity.
ADAMTS activators are aimed at understanding molecules that can specifically or indirectly modulate the activity of ADAMTS family members. While several types of molecules are being investigated for their role in activating or facilitating ADAMTS function, these range from small organic compounds to larger biological molecules. Small molecules like HDAC and TGF-β have been researched for their impact on the epigenetic and transcriptional regulation of ADAMTS family members, respectively. Others like MMP can indirectly contribute by preserving the availability of substrates in the ECM for ADAMTS proteins. Activators may also interact with ADAMTS members through various mechanisms such as inhibition of opposing pathways or through complex signaling cascades.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | ¥1467.00 ¥3046.00 | 37 | |
HDAC 抑制剂可能会影响 ADAMTS-20 基因表达的表观遗传调控。 | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | ¥903.00 ¥2392.00 ¥4603.00 | 48 | |
如果 TGF-β 是一种抑制因子,那么通过抑制 TGF-β,就有可能上调 ADAMTS-20 的表达。 | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | ¥3159.00 | 4 | |
DNA 甲基转移酶抑制剂会影响 ADAMTS-20 基因的甲基化状态,可能会增加其表达量。 | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | ¥372.00 ¥824.00 ¥2990.00 ¥1264.00 | 34 | |
可通过减少抑制 ADAMTS-20 的氧化应激条件来激活 ADAMTS-20。 | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | ¥688.00 ¥936.00 ¥3937.00 | 155 | |
如果 NF-κB 起到抑制作用,那么 NF-κB 抑制剂有可能通过抑制 NF-κB 信号来上调 ADAMTS-20。 | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | ¥395.00 ¥1297.00 ¥5810.00 | 26 | |
Wnt 通路抑制剂可能会通过影响已知参与 ECM 重塑的 Wnt 信号来影响 ADAMTS-20。 | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | ¥1162.00 ¥3306.00 ¥5246.00 | 15 | |
PKC 抑制剂可影响各种信号通路,从而间接激活 ADAMTS-20。 | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | ¥2775.00 ¥5528.00 ¥6047.00 | 16 | |
JAK/STAT 抑制剂可能会影响影响 ADAMTS-20 表达或活性的细胞因子信号。 | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | ¥1264.00 ¥1839.00 ¥10470.00 | 19 | |
MEK 抑制剂可能会影响影响 ADAMTS-20 的 MAPK 通路。 | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | ¥711.00 ¥1952.00 | 7 | |
HIF-1α 稳定剂可能会影响与缺氧相关的 ADAMTS-20 的激活或表达。 |